Clinical Trials Logo

Hypoparathyroidism clinical trials

View clinical trials related to Hypoparathyroidism.

Filter by:

NCT ID: NCT03249012 Recruiting - Quality of Life Clinical Trials

Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study aims to compare two different protocols commonly used in the management of post thyroidectomy hypoparathyroidism : PTH based calcium repletion and empiric repletion. The investigators aim to compare the quality of life associated with these two protocols in a randomized trial.

NCT ID: NCT03194087 Recruiting - Clinical trials for Secondary Hyperparathyroidism

the Study on Prognostic for Hemodialysis Patients

Start date: January 1, 2017
Phase: N/A
Study type: Observational

Results from KDOQI guidelines, parathyroid hormone (PTH) level within target range is 150-300pg/ml. Both lower PTH levels and higher PTH levels were associated with higher risk of all-cause mortality. However, in out of target range, it is still unknown which mortality higher. so, in this prospective, observational clinical trial study. the investigators will observe the mortality and cardiovascular incidence rate between SHPT(>800pg/ml) and low serum PTH levels(<60pg/ml). Both two groups of patients will receive a reasonable treatment according to the suggestions in K/DOQI guidelines.

NCT ID: NCT02986607 Recruiting - Hyperparathyroidism Clinical Trials

Corticosteroid Rhythms in Hypoparathyroid Patients

Start date: March 2016
Phase: Early Phase 1
Study type: Interventional

The investigators hypothesise that parathyroid hormon (PTH) depletion interferes with normal activity of the hypothalamus-pituitary-adrenal (HPA)-axis and the renin-angiotensin-aldosterone-system (RAAS), which in turn may impact morbidity and quality of life. The main objective of the current study is to test if PTH deficiency influences the secretion of corticosteroids and whether any abnormalities in the HPA-axis and the RAAS-system can be reversed by PTH infusion.

NCT ID: NCT02838927 Recruiting - Hypoparathyroidism Clinical Trials

Survey on Epidemiology of Hypoparathyroidism in France

Epi-Hypo
Start date: July 2016
Phase:
Study type: Observational

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

NCT ID: NCT02652884 Recruiting - Clinical trials for Transient Hypoparathyroidism

Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy

Corthyroid
Start date: January 2016
Phase: Phase 4
Study type: Interventional

The incidence of thyroid cancer (TC) has increased exponentially worldwide. The increase in diagnosed cases brings about an increase in the number of surgeries performed on the thyroid gland, especially total thyroidectomy (TT), given that at present is still the gold standard of treatment. Transient postoperative hypoparathyroidism (HPT) is one of the most frequent complications, with an incidence of between 10 and 46% according to different sources. HPT involves longer hospital stay, serial measurements of blood glucose, treatment with calcium and vitamin D (with potential risk of hypercalcemia) and therefore an increase in terms of the costs of the health system. While the investigators know the analgesic, anti-inflammatory, immunomodulatory and anti emetic of corticosteroids in thyroid surgery, the literature available to date is discordant in the use of steroid and its interaction with the HPT making clear the need for randomized clinical trials specific to analyze these variables more accurately. As inflammation and edema constitute a proposed surgical manipulation in the pathogenesis of HPT component, investigators decided t conduct a prospective randomized, triple-blind, in order to assess the potential benefits of the most common postoperative complication reported in TT. Our primary objective is to evaluate the safety and efficacy of single-dose corticosteroids deposit immediately postintubation in preventing the development of transient hypoparathyroidism (PTH, serum calcium and symptoms) in patients after TT.

NCT ID: NCT01039714 Recruiting - Clinical trials for Vitamin D Deficiency

Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy

Start date: December 2009
Phase: N/A
Study type: Observational

Hypocalcemia is one of the most frequent complications of total thyroidectomy, a procedure used for benign as well as malignant conditions of the thyroid gland. Postoperative hypocalcemia is usually caused by hypoparathyroidism. Vitamin D is implicated in calcium metabolism as it increases intestinal calcium transport and regulates parathormone production. Aim of the present study is to evaluate preoperative vitamin D levels as a prognostic factor for postoperative hypocalcemia and hypoparathyroidism.